Global Antidotes Market, By Type (Chemical Antidotes, Physical Antidotes, Pharmacological Antidotes, Others), Route of Administration (Oral, Parenteral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Antidotes Market Analysis and Size
Over 1 million snake bites are recorded in Africa annually, the World Health Organization reports, resulting in 50,000 individuals needing medical attention, 25,000 deaths, and another 25,000 people with long-term disabilities. The rise in medical conditions requiring antidotes, such as nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning, is likely to fuel the market's growth during the forecast period.
Data Bridge Market Research analyses that the antidotes market, which is USD 1.91 billion in 2022, is expected to reach USD 3.94 billion by 2030, at a CAGR of 9.5% during the forecast period 2023 to 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Antidotes Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Chemical Antidotes, Physical Antidotes, Pharmacological Antidotes, Others), Route of Administration (Oral, Parenteral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd (India), Aurobindo Pharma (India), Mylan N.V. (U.S.), Akorn Operating Company LLC (U.S.), Alvogen (U.S.), Fresenius Kabi AG (Germany), Zydus Cadila (India), Daiichi Sanko Inc. (Japan), Nichi-Iko Pharmaceutical Co., Ltd (Japan)
|
|
Market Opportunities
|
|
Market Definition
Antidotes are agents that counter the effects of a poison or toxin. Antidotes counter the toxin's effects by either limiting absorption, binding with the poison, and neutralizing it, countering the poison's end-organ effects, or inhibiting the toxin's conversion to more hazardous metabolites. By using mechanisms such as competitive inhibition, receptor blockage, or direct antagonism of the toxin, antidote delivery may not only decrease the level of free or active toxin. Still, it may also mitigate the effects of the toxin on end organs.
Antidotes Market Dynamics
Drivers
- Rising prevalence of snake bites will propel the market growth
The main market drivers are the prevalence of snake bites and the unfavourable outcomes related to them. The WHO estimates that 4.5–5.4 million people are bitten by snakes annually, 1.8–2.7 million of them develop clinical illness (envenoming), and 81,000–138,000 people die from the bite. This is the main factor fueling the market for antidotes. The rise in drug overdoses also fuels the demand for antidotes.
For instance, The World Health Organization estimates that more than 1 million snake bites occur in Africa each year, leaving 50,000 people in need of medical attention, 25,000 people dead, and another 25,000 permanently disabled. An increase in medical issues requiring antidotes is due to nerve agent poisoning, methotrexate rescue, methanol poisoning, mercury poisoning, lead poisoning, and gold poisoning. The market is anticipated to expand quickly during the forecast period.
Opportunities
- Rising metal toxicity will act as an opportunity
An important component of the market is dominated by heavy metal toxicity. In addition to rising water contamination, using herbal remedies containing heavy metals is one of the main factors driving category expansion. The most frequent effects of heavy metal toxicity include anemia, miscarriages and early labor. Chelation, or using chemical countermeasures, is a crucial component of treatment. 25.8% of the world's population, or 1.62 billion, suffer from anemia (95 percent confidence interval: 1.50-1.74 billion). Therefore, these variables play a role in sector growth.
Restraints/Challenges
- Lack of skilled professionals and other miscellaneous factors will hinder the growth
The development of the worldwide antidotes market during the forecast period may be restrained by a shortage of competent employees who cannot treat patients with these compounds. In addition, a number of limitations in the antidote market, including the poor availability of anti-venoms due to growing anti-venom costs and restricted demand are anticipated to impede the market's expansion.
This antidotes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antidotes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Antidotes Market
COVID-19 has left behind an extraordinary global public health disaster that has impacted almost every industry. Its long-term effects are anticipated to have an impact on industry growth during the forecast period. Clinical trial delays and drug launch cancellations have resulted from the shift in healthcare infrastructure toward addressing COVID-19. The need for a COVID-19 vaccine and treatment medications in the post-pandemic era is anticipated to fuel significant future growth in the biotechnology and pharmaceutical sectors. As a result, the market for antidotes will be significantly impacted.
Global Antidotes Market Scope
The antidotes market is segmented on the basis of type, end-users, route of administration, distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Chemical Antidotes
- Physical Antidotes
- Pharmacological Antidotes
- Others
Route of Administration
- Oral
- Capsules/tablets
- Syrups
- Parenteral
- Injectable
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Antidotes Market Regional Analysis/Insights
The antidotes market is analysed and market size insights and trends are provided by country, type, end-users, route of administration, distribution channel as referenced above.
The countries covered in the antidotes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the antidotes market due to an increase in antidote research and development activities, an increase in poison incidents.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to an increase in activities by the government and specialized communities, the vast number of generic manufacturers and expanding healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Antidotes Market Share Analysis
The antidotes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antidotes market.
Some of the major players operating in the antidotes market are:
- Pfizer Inc (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
- Dr. Reddy's Laboratories Ltd (India)
- Aurobindo Pharma (India)
- Mylan N.V. (U.S.)
- Akorn Operating Company LLC (U.S.)
- Alvogen (U.S.)
- Fresenius Kabi AG (Germany)
- Zydus Cadila (India)
- Daiichi Sanko Inc (Japan)
- Nichi-Iko Pharmaceutical Co., Ltd (Japan)
SKU-